Compounds > carmustine

carmustine and esmolol

carmustine has been researched along with esmolol in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (80.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Bruce, JN; Cooper, TB; Etu, JJ; Feinmark, SJ; Fine, RL; Joshi, S; Suckow, RF; Wang, M	1

Other Studies

5 other study(ies) available for carmustine and esmolol

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Transient cerebral hypoperfusion enhances intraarterial carmustine deposition into brain tissue. Journal of neuro-oncology, 2008, Volume: 86, Issue:2 Topics: Adenosine; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Antineoplastic Agents, Alkylating; Brain; Carmustine; Carotid Arteries; Cerebrovascular Circulation; Chemotherapy, Cancer, Regional Perfusion; Dose-Response Relationship, Drug; Infusions, Intra-Arterial; Infusions, Intravenous; Intracranial Hypotension; Ischemic Attack, Transient; Male; Propanolamines; Rabbits; Statistics, Nonparametric; Vasodilator Agents	2008